The novel therapy of the medication represents a exciting breakthrough in the management of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide043970.blogginaway.com/42804263/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment